Rehabilitation of children with severe acute malnutrition with ready-to-use therapeutic food compared to F100 at Clairwood Hospital, KwaZulu-Natal by Nomvete, Anele Yoliswa
REHABILITATION OF CHILDREN WITH SEVERE ACUTE MALNUTRITION WITH 
READY-TO-USE THERAPEUTIC FOOD COMPARED TO F100 AT CLAIRWOOD 
HOSPITAL, KWAZULU-NATAL 
 
 
By 
 
 
ANELE YOLISWA NOMVETE 
 
 
 
 
 
Submitted in partial fulfilment of the requirements for the degree of 
 
MAGISTER ARTIUM IN HEALTH AND WELFARE MANAGEMENT 
 
at the Nelson Mandela Metropolitan University 
 
 
 
 
 
 
 
 
DECEMBER 2013 
 
 
 
 
 
 
 
 
 
 
 
Supervisor: Dr. L. STEENKAMP 
 
Co-supervisor: Dr. J. Von der MARWITZ 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
  
DECLARATION 
I, Anele Yoliswa Nomvete, declare that:  
 This research paper in partial fulfilment for the degree Magister Atrium in Health and Welfare 
Management is my own work. 
 This research has not previously been submitted by me or anyone else for assessment to another 
university or for another qualification. 
  
 
SIGNATURE:      DATE: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
ACKNOWLEDGEMENTS 
This treatise would have not been possible without the kindness, support, knowledge, and advice of my 
leaders Dr. L. Steenkamp and Dr. J. Von der Marwitz. Thank you.   
 
I would also like to express my sincere gratitude to the following individuals and organisation: 
 The Department of Health KwaZulu-Natal, Hospital manager and the staff working in the 
 paediatric wards at Clairwood hospital. 
 
 Mr D. Venter, for statistical analysis. 
 
 The subjects who participated in the study, without them the study wouldn’t have been possible. 
 
 Diva Nutritional Products. 
 
 Very special thanks to my husband and sons (Fikile, Sibabalwe and Usivuzile), my parents, my 
 family and friends for their patience, encouragement and support during this time. 
 
 Above all, I thank my Heavenly Father who gave me strength, courage and perseverance to 
 complete this study. 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
TABLE OF CONTENTS                    PAGE 
Acknowledgements           iii 
List of tables            viii 
List of figures            ix 
List of addendums           ix 
List of abbreviations           x, xi 
Abstract             xii 
 
CHAPTER 1: OVER VIEW OF THE STUDY 
1.1 Introduction           13 
1.2 Problem statement          15 
1.3 Aims and objectives          16 
1.4 The role of the researcher          17 
1.5 Benefits of the study          17 
1.6 Outline of chapters          17 
 
CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction           18 
2.2 Prevalence of underweight, stunting and wasting      18 
2.3 Public health approaches to address malnutrition      19 
2.4 Malnutrition in South Africa         20 
2.5 Diagnosing severe acute malnutrition        20 
2.6 Diseases associated with severe acute malnutrition      21 
2.6.1 Diarrhoea           21 
v 
 
2.6.2 Co-morbid diseases          22 
2.6.3 Human Immunodeficiency Virus and opportunistic infections     22 
2.7 Mortality in severe acute malnutrition        22 
2.8 Dietary management of severe acute malnutrition      23 
2.8.1 Efficacy of World Health Organisation guidelines      23 
2.8.2 Ready-to-use-therapeutic food          24 
2.8.2.1 Recommendations for use         25 
2.8.2.2 Research outcomes: treatment of severe acute malnutrition     25 
2.8.2.3 Time to recovery          25 
2.8.2.4 Expected growth velocity         26 
2.9 Integration services          28 
2.10 Summary            29 
 
CHAPTER 3: METHODOLOGY 
3.1 Introduction           30 
3.2 Methods            30 
3.2.1 Study design           30 
3.2.2 Population           30 
3.2.3 Sampling           31 
3.2.4 Sample size           31 
3.3 Procedures and interventions         32 
3.3.1 Procedures           32 
3.3.1.1 Monitoring sheet          32 
3.3.2 Variables           32 
vi 
 
3.3.2.1 Weight           32 
3.3.2.2 Height            32 
3.3.2.3 Mid-upper arm circumference        33 
3.3.2.4 Rate of weight gain          33 
3.3.2.5 Interventions           33 
3.4 Pilot study            34 
3.5 Statistical analysis          35 
3.6 Ethical consideration          35 
3.7 Reliability            36 
3.8 Validity            36 
3.9 Limitations           36 
 
CHAPTER 4: RESULTS 
4.1 Introduction           37 
4.2 Demographics           37 
4.3 Description of sample          38 
4.4 Clinical signs on admission         39 
4.5 Symptoms            39 
4.6 Morbidity and Mortality          39 
4.7 Rate of weight gain          40-41 
4.8 Time to recovery           42 
4.9 Height and mid-upper arm circumference       43 
4.9.1 Height            43  
4.9.2 Mid-upper arm circumference         43-44 
vii 
 
4.10 Summary          45 
 
CHAPTER 5: DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
5.1 Introduction           46 
5.1.1 Demographic information         46 
5.1.2 Human Immunodeficiency Virus and Tuberculosis      46 
5.1.3 Clinical signs and symptoms         46 
5.1.4 Morbidity and mortality         47 
5.1.5 Rate of weight gain          47 
5.1.6 Time to recovery          47 
5.1.7 Mid-upper arm circumference         48 
5.2 Conclusion           48 
5.3 Recommendations          48-49 
Bibliography            51-57 
Addendums            58-68 
 
 
 
 
 
 
 
 
viii 
 
LIST OF TABLES 
Table 2.1: Worldwide burden of acute malnutrition in children aged less than 5 years 
Table 2.2: WHO classification of SAM 
Table 2.3: Implementation phases for the management of a child with severe malnutrition  
Table 3.1: Criteria for SAM in children aged 6-60 months 
Table 3.2: Comparison of the nutritional composition of RUTF and F100 
Table 4.1: Gender of children  
Table 4.2: Age of children  
Table 4.3: Gender distribution between groups 
Table 4.4: Age distribution between groups 
Table 4.5: Diseases affecting the children 
Table 4.6: Growth Velocity between groups 
Table 4.7: Weight gain between groups 
Table 4.8: Recovery rates between RUTF and F100 group 
Table 4.9: Overall recovery rates in the RUTF group and F100 group 
Table 4.10: MUAC changes 
 
 
 
 
  
 
 
 
ix 
 
   
LIST OF FIGURES 
 
Figure 1.1 UNICEF conceptual framework of the causes of malnutrition.  
Figure 2.1: Summary of SAM management 
Figure 4.1 Weight gain in children between groups 
Figure 4.2 Growth velocity between groups 
Figure 4.3 WHZ score ≥-1   
 
LIST OF ADDENDUMS 
Addendum A: Steps for the management of severe malnutrition 
Addendum B: Consent form 
Addendum C: Permission to conduct research study 
Addendum D: Questionnaire on nutritional assessment 
Addendum E: Explanation of the purpose for this research to the parents and legal guardians 
Addendum F: Approval of research proposal 
Addendum G: Range of volumes for free feeding with F-100  
 
 
 
 
 
 
 
 
x 
 
LIST OF ABREVIATIONS 
AIDS   Acquired Immunodeficiency Syndrome 
ART   Anti-retroviral Treatment 
DALY   Disability-adjusted-life years 
DBSA   Development Bank of South Africa 
FAO   Food and Agriculture Organisation 
FAS   Foetal Alcohol Syndrome 
HAZ   Height-for-age Z-score 
HIV   Human Immunodeficiency Virus 
INP   Integrated Nutrition Programme 
Kcal   Kilocalories 
MUAC  Mid-upper arm circumference 
MTCT   Mother-to-child transmission 
NCHS   National Centre for Health Statistics 
NRU   Nutrition Rehabilitation Units 
ORS   Oral Rehydration Solution 
RUTF   Ready-to-use therapeutic food 
SAM   Severe Acute Malnutrition 
SD   Standard Deviation 
UNICEF  United Nations Children Fund 
TB   Tuberculosis 
UNICEF  United Nations Children Fund 
UN   United Nations 
WHZ   Weight-for-height Z-score 
xi 
 
WAZ   Weight-for-age Z-score 
WHO   World Health Organisation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
ABSTRACT 
Background: The World Health Organisation (WHO) initially recommended F100 formula in the 
treatment of severe malnutrition. F100 is made with full cream milk powder, sugar, oil and water with 
added minerals and vitamins. Ready to-use therapeutic food (RUTF) is a highly nutrient dense food 
enriched with minerals and vitamins, with a similar nutrient profile but greater energy and nutrient 
density than F100. RUTF has shown to be effective in the treatment of severe and moderate wasting 
and is associated with an increased recovery rate. In South Africa no studies are available on the 
recovery rate of children with severe acute malnutrition treated with RUTFs. 
Aim: To compare the recovery of clinically stable severe acute malnourished children, between the age 
of 12 and 60 months, treated with either F100 or RUTF as nutrition supplement.  
  
Methods: A randomised clinically controlled trial was performed. All children referred to Clairwood 
hospital with severe acute malnutrition (SAM), defined as a weight for height measurement of <70% of 
the median and/or < -3 SD below the mean WHO reference values or the presence of bilateral oedema 
were included in this study. Children were stratified according to age and gender and subsequently 
randomly assigned with randomisation tables to either the RUTF or F100 group. A total of 35 children 
were included in this study and data from 34 were analysed with 17 in each group.  
Results: Most children included in this study were between 12 and 18 months with boys in the 
majority. Both groups had a large percentage of HIV-infected children (70% in the RUTF group and 
76% in the F100 group), with Tuberculosis (TB) co-infection in some of the children. One child died 
due to HIV related complications. The rate of weight gain was 7.77g/kg/day in the RUTF group and 
6.11g/kg/day in the F100 group. There was no statistical significant difference established between 
groups (p = 0.46). The majority of children recovered within 21 days on the RUTF while the majority 
of children in the F100 group recovered after 6 weeks. There were no changes in height  during the 
rehabilitation of these children. MUAC changes were observed with 92% having a mid-upper arm 
circumference (MUAC) of > 11.5cm after a 6 week intervention with RUTF and F100. 
Conclusion: RUTF resulted in better rates of recovery and can be used efficiently in rehabilitating 
children with SAM in a supervised facility setting. These preliminary results also point towards 
significant potential savings regarding hospitalisation costs since faster recovery has been demonstrated 
by children in the RUTF group. 
 
Keywords: SAM, RUTF, F100, growth velocity, time to recovery.
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CHAPTER ONE 
OVERVIEW OF THE STUDY 
1.1 Introduction 
Malnutrition continues to be a major health problem in developing countries, especially in southern 
Asia and sub-Saharan Africa (UNICEF, 2008). The World Health Organisation (WHO) describes 
malnutrition as inadequate or excess intake of protein, energy, and/or micronutrients and often 
accompanied by frequent infections or disease. Inadequate water supply, poor sanitation and poor 
hygiene may also contribute to infectious diseases, especially waterborne diseases which may result in 
diarrhoea (WHO, 2000). Macro environmental factors may be linked to poverty and unemployment, 
which may also contribute to malnutrition (Schuftan, 1988). 
 
The conceptual framework, developed by UNICEF (Figure1.1) shows the levels of cause and effect 
that ultimately lead to malnutrition and death. The framework also illustrates the relationship between 
poverty, food security, and other underlying and immediate causes.  When viewed from bottom to top, 
a more positive view is presented on how to prevent malnutrition. 
 
 Manifestations 
       
   Immediate Causes 
                                                                                                                            
  
 Underlying 
 Causes 
 
 
 
 Basic  
                                              Political and Ideological Superstructure Causes 
                                                                           
                                                                          Economic Structure 
                                                                              
 
 
Figure 1.1 UNICEF conceptual framework on the causes of malnutrition. (UNICEF, 1998) 
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Severe acute malnutrition (SAM) is defined by the WHO as a weight-for-height (WFH) measurement 
below -3 Standard Deviations (SD) or less than 70% of the median of the National Centre for Health 
Statistics (NCHS)/WHO reference values with or without oedema (WHO, 2009). 
 
The WHO developed treatment guidelines during 1999 for the management of SAM. The WHO 
management protocol consist of ten steps (Addendum A). This protocol is suitable for inpatient use in a 
clinical setting as well as in rehabilitation centres after the stabilisation phase is completed in the 
hospital (WHO, 1999). Training of health care workers or the multi-disciplinary team is essential for 
the implementation of this WHO guideline (Ashworth et al., 2003). The WHO management protocol is 
used worldwide yielding positive outcomes and has proved to decrease case fatality rates in units in 
Bangladesh, South Africa and Brazil (Collins, 2007).  
 
The WHO ten steps are divided into three phases: the initial stabilisation phase, the rehabilitation phase 
and follow-up phase. During the initial stabilisation phase, the child is stabilised by correcting 
deficiencies and reversing metabolic abnormalities. Feeding is initiated during this phase to treat or 
prevent hypoglycaemia. The WHO recommends F-75 formula as a starter formula during this phase. F-
75 is a milk-based formula, consisting of full cream milk, sugar, and oil, with a mineral mix added to it. 
F-75 provides 75kcal/100ml and 0.9g protein/100ml (Ashworth et al., 2003). 
 
In the rehabilitation phase, the child is clinically stable and ready for aggressive feeding in order to 
recover the lost weight. In 1999, the WHO recommended F100 during the rehabilitation phase  in the 
treatment of severe malnutrition. F100 is a high energy milk-based formula and made with full cream 
milk powder, sugar, oil and water with minerals and vitamins added to the formula. It provides 2.9g of 
protein and 100kcal energy per 100ml. The transition from F-75 to F100 should be gradual to avoid the 
potential risk of cardiac failure as a result of consuming large volumes of feed which places an 
additional burden on the heart.  The F-75 formula is replaced with an equal amount of F100 for two 
days before increasing the volume. (WHO, 1999) 
 
Mental and behavioural development is delayed in children with SAM. Emotional and physical 
stimulation through play programmes must start during rehabilitation and continue after discharge. In 
these programmes, the child is physically stimulated and the mother or the caregiver is counselled and 
trained to continue providing care at home. (Ashworth et al., 2003)  
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The final phase, the follow-up phase, is there to prevent a relapse. The mother or caregiver are followed 
up and supported in order to ensure the continued physical, mental and emotional development of the 
child. These steps are described in more detail in Addendum A.   
 
A time period of about two to three weeks should be adequate to enable the child to progress to the 
rehabilitation phase. In the rehabilitation phase the child’s appetite is normally improved and he or she 
is able to consume F100 together with a mixed diet, resulting in rapid weight gain due to the increase in 
energy intake. Weight gain, expressed as growth velocity (grams gained per kg body weight per day), is 
ideally about 10-15g/kg per day. Weight gain at this rate should enable the child to reach the target 
weight for discharge within two to four weeks. The target weight is usually approximately -1 SD (90%) 
of the median NCHS/WHO reference values for the weight-for-height z-score (WHO, 1999). 
 
A joint statement by the WHO, the World Food Programme, the United Nations Systems Standing 
Committee on Nutrition and the United Nations Children’s Fund (UNICEF) in 2007, introduced 
Ready-to-use therapeutic food (RUTF) in the treatment of SAM in uncomplicated cases and at 
community level (WHO, 2007). RUTF is similar to F100 in nutrient composition, but has a low water 
activity that inhibits microbial growth (Briend, 2001). 
 
A study in Senegal compared the efficacy of RUTF and F100 in promoting weight gain in 
malnourished children. Children aged 6 to 36 months were randomly allocated to receive either RUTF 
or F100 in addition to the local diet. Energy intakes (808kJ/kg/day vs 573kJ/kg/day), rates of weight 
gain (15.6g/kg/day vs 10.1g/kg/day) and time to recovery (13·4 days versus 17.3 days) were all 
significantly greater in those receiving RUTF than in those receiving F100. The results suggested that 
RUTF may be a more effective choice than F100 in promoting weight gain in a supervised setting 
(Diop et al., 2003). 
     
1.2 Problem Statement  
 
Approximately 3.5% of children worldwide are affected by severe wasting with 2.1million or 21% of 
global annual deaths attributed to amongst others stunting, severe wasting, intrauterine growth 
restriction and low birth weight (Black et al., 2008). In children less than 5 years of age malnutrition is 
an underlying factor in approximately 50% of nearly 10 million deaths from preventable causes (Black, 
Morris & Bryce, 2003). 
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In South Africa 3.6% of children are severely malnourished with a WHZ below the -3SD (UNICEF, 
2007). 
The Health Systems Trust 2011 Report on severe malnutrition incidences by districts showed that 
KwaZulu-Natal had the highest SAM rates. This report indicated the figure for eThekwini district at 6.9 
per 1000, which exceeded both the national (4.8 per 1000) and metro averages for 2010/2011 (Health 
Systems Trust, 2011). At eThekwini district, Clairwood rehabilitation hospital admits stable children 
with SAM that require further nutrition rehabilitation from five other hospitals in close proximity. 
Approximately 35% of total admissions in this hospital’s paediatric wards in 2011 were SAM cases. 
The duration of hospital stay was about 8 weeks or longer for these patients. Prolonged hospital stays 
are costly; therefore it is important to determine the efficiency of RUTF in the treatment of SAM in 
terms of growth velocity and recovery rate. Results from research may indicate whether improved rates 
of recovery and decrease duration of hospital stay are possible by replacing F100 with RUTFs. 
 
RUTF has been shown to be effective in the treatment of severe and moderate wasting and is associated 
with an increased recovery rate in other parts of Africa (Ciliberto et al., 2005). RUTFs are accessible to 
all health facilities in South Africa, on the RT9 government contract. However, in South Africa no 
studies are available on the recovery rate of children with SAM treated with RUTFs. 
 
The research question is therefore whether faster recovery of clinically stable children with SAM is 
possible in Clairwood hospital if RUTF is used instead of F100. 
 
1.3 Aims and Objectives 
The aim of this study was to compare the recovery of clinically stable severe acute malnourished 
children, between the age of 12 and 60 months, treated with either F100 or RUTF as the main nutrition 
supplement.  
 
In order to reach this aim the objectives were to determine: 
-  the rate of weight gain; 
- timeframe to recovery; 
- changes in height and mid-upper arm circumference (MUAC); 
- morbidity and mortality; and 
- retention in the programme. 
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1.4 The role of the researcher 
The researcher is a trained dietician, employed at Clairwood hospital. The researcher developed the 
study protocol and was responsible for screening and monitoring of patients that participated in the 
study. During the screening process weights; MUAC and height were taken and recorded. The 
researcher was also responsible for the interpretation, presentation of results and writing of the research 
report. 
 
1.5 Benefits of the study 
The results obtained from the study will be used to guide treatment protocols for SAM in the 
eThekwini district and the greater KwaZulu-Natal region and South Africa. 
 
1.6 Outline of Chapters 
 
The first chapter gives the background of the study, problem statement and describes the aim and 
objectives. 
The second chapter contains literature on the prevalence of malnutrition globally, the South African 
perspective and a global perspective on malnutrition. Underlying and immediate causes of malnutrition 
are discussed. In this chapter the screening and treatment for SAM is discussed, including the role of 
RUTF versus F100. Expected rates of weight gain on these supplements are also included in this 
chapter.  
The third chapter describes the design and methodology used in the study. 
The fourth chapter describes the results of the study. 
In the fifth chapter, discussions, conclusions and recommendations are presented. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Introduction 
Malnutrition is a major risk factor contributing to the high burden of disease and mortality in young 
children (Black et al., 2008). The WHO (WHO, 2000) describes malnutrition as an invisible 
phenomenon casting shadows and affecting close to 800 million people - which also: 
 kills, maims, cripples and blinds on a massive scale worldwide;  
 affects one in three people worldwide, afflicting all age groups and populations especially           
 the poor and vulnerable;  
 plays a major role in half of the 10.4 million annual child deaths in the developing world and      
continues to be a cause and consequence of disease of disease and disability in children who 
survive; 
 is not only medical but a social disorder rooted in poverty and discrimination; and 
 has economic ripple effect that can jeopardize development. 
 
2.2 Prevalence of underweight, stunting and wasting 
According to Black et al. (2008) globally an estimated 55 million of children under 5 years of age, are 
wasted with a WHZ less than -3.  
Statistics from 2005 also reflected that 20% of children younger than 5 years of age in low-income and 
middle-income countries, have a weight-for-age Z score (WAZ) of less than -2SD which is reflecting 
of wasting. The prevalence of wasting is the highest in South-Central Asia and eastern Africa with 
figures of 33% and 28% respectively. At the same time, an estimated 32% (178 million) of children 
less than 5 years of age in developing countries had a height-for-age Z score (HAZ) less than -2SD, 
reflecting stunting. (Black et al., 2008) 
 
Prevalence of underweight, stunting, and wasting worldwide and for United Nations (UN) regions are 
based on analysis of 388 national surveys from 139 countries represented in table 2.1. 
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Table 2.1: Worldwide burden of acute malnutrition in children aged less than 5 years (Black et 
al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   *weight for height (WFH)  
 
 
2.3 Public health approaches to address malnutrition 
The United Nations (UN) millennium development goal number four is to reduce child mortality by 
two-thirds by 2015 (United Nations, 2006). Reductions in child mortality can only be achieved by 
interventions that are available and feasible for implementation in low-income countries. The public 
health system is easily accessible to the poor and can be used to reach poor families. Stakeholders must 
ensure the availability of resources and reliability of the system. (Jones et al., 2003) 
 
Bryce et al. (2003) argued that in order for the systems to be sustainable, the system must take into 
account indicators of health-system strength and infrastructure, current coverage and utilization, care 
seeking patterns, public and private health infrastructure, financing options, and human resource. 
Public health programmes that are planned, implemented, and assessed well, tackling a number of 
diseases, can make a difference. 
  
Regions Under-5 
population 
2000 (x1000) 
Wasting prevalence 
(%) 
Wasting numbers 
(x1000) 
Annual mortality numbers 
Moderate 
and severe 
Severe ≥2 Z 
scores 
below 
WFH 
≥3 Z 
scores 
below 
WFH 
2-3 Z-
scores 
below 
WFH 
>3 Z 
scores 
WFH  
Total 
Sub-Saharan 
Africa 
106 394 10 3 10 639 3192 565 768 421 767 987 535 
Middle East and 
North Africa 
44 478 7 2 3141 890 168 942 117 547 286 489 
South Asia 166 566 15 2 24 985 3331 1644 950 440 201 208 5151 
East Asia and 
Pacific 
159 454 4 - 6378 - 484 528 - 484 528 
Latin American 
and Caribbean 
54 809 2 0 1096 - 83 273 - 83 273 
CEE-CIS and 
Baltic States 
300 20 4 1 1201 300 68 416 39 668 108 084 
Industrialised 
countries 
50 655 - -   - - - 
Developing 
countries 
546 471 9 2 49 182 10 929 2905 951 1444 214 4350 164 
Least developed 
countries 
110 458 10 2 11 046 2209 671 290 291 918 963 209 
Total 707 584   60 228 13 139 3577 241 1736 132 5313 373 
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Inequities in child health have been reported and are unacceptable worldwide, both between and within 
countries. The WHO and UNICEF are therefore responsible to address equity in child health. The 
poorest of the poor are victims of these inequities as they are often left behind when progress is made in 
child health. (Victoria et al., 2003) 
 
2.4 Malnutrition in South Africa  
The National Food Consumption Survey (NFCS) showed that among children 1-9 years of age 52% 
reported to experience hunger, 23% were at a risk of hunger and 25% were food secure. And the 
national prevalence for severe stunting was 6.5% and for severe wasting was 0.8% and under-nutrition 
was highest in rural areas and commercial farms (Labadarios et al., 2005). 
The Development Bank of Southern Africa (DBSA) reported that in 1995 the South African 
Department of Health initiated the Integrated Nutrition Programme (INP) to address and prevent 
malnutrition. A comprehensive approach was used to address the underlying causes of malnutrition 
through direct (nutrition education and promotion; micronutrient supplementation; food fortification; 
and disease-specific nutrition counselling and support) and indirect (provision of healthcare services; 
improving access to food; parasite control and provision of clean and safe water) nutrition interventions 
which included service delivery (DBSA, 2008). 
The South African government have policies designed to address food insecurities and the policies 
have led to development of programmes such as school feeding programmes, day centre schemes and 
social grants which have been put into effect and enforced (Labadarios et al., 2011). 
The high prevalence of SAM in developing countries require urgent treatment (Black et al., 2008). 
Early identification and recognition of SAM among children is important. The risk of death in children 
with SAM is high and the WHO recommends the use of diagnostic criteria for early identification of 
SAM (WHO, 2009).  
 
2.5 Diagnosing SAM 
In 2009, the WHO published child growth standards for the identification of SAM in infant and 
children 6 to 60 months of age. Anthropometric measurements are recommended for the screening of 
SAM. A WHZ <-3 SD is a highly specific criterion to identify severely acutely malnourished infants 
and children. Children with a WHZ <-3 SD based on the WHO standards have a high risk of mortality 
and those with WHZ >-2 and -1 SD have a lower mortality risk. MUAC measurement is also used for 
the screening of children with SAM. A higher cut-off of 11.5cm than the earlier 11.0cm is 
21 
 
recommended as it will identify more children as having SAM. Children with a MUAC less than 
11.5cm have a high mortality risk compared to those with a MUAC above 11.5cm. MUAC is easy to 
use and efficient in identifying children with SAM (Table 2.2) (WHO, 2009). 
 
Table 2.2: WHO Classification of SAM (UNICEF, 2011 & WHO, 2009) 
 Moderate Malnutrition Severe Malnutrition 
Bilateral oedema No Yes 
WHZ (wasting) SD score -3 and <-2 
≥70% and <80% reference 
SD score <-3 
<70% reference 
MUAC ≥11.5 cm & <12.5cm <11.5cm 
 
The WHO child growth standards to identify the severely malnourished children 6-60 months, 
classifies two to four times as many children compared to the NCHS reference. 
Isanaka et al. (2009) assessed the impact of the introduction of the WHO growth standards and WHZ 
criterion on the response to treatment of SAM in children. The results showed an eight times higher 
number of children with SAM identified with the WHO growth standards than the number identified 
with the use of the NCHS reference and WHZ < 70% median criterion. Because of earlier diagnosis, 
children identified by the WHO standards experienced shorter durations of treatment, greater rates of 
recovery, lower frequencies of death and less need for inpatient care. Notably SAM children identified 
using the WHO standards also had fewer medical complications and a lower mortality rate.  
 
2.6 Diseases associated with SAM 
2.6.1 Diarrhoea 
The presence of diarrhoea not only complicates the treatment of SAM, but has been shown to be a 
major complication in children with SAM and responsible for high mortality rates (Irena et al., 2011). 
In a study by Talbert et al. (2012) results showed that 49% of hospitalised children with SAM had 
diarrhoea as a complication and an increased risk for death.  
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2.6.2 Co-morbid disease  
A review of eleven studies showed that severe malnutrition is associated with a high risk of mortality in 
children with pneumonia. The contributing factors to the increased mortality risk highlighted in this 
review include immunodeficiency associated with malnutrition, high rates of co-morbidities, and delays 
in diagnosis due to the insensitivity of clinical signs (Christi et al., 2009).  
 
2.6.3 HIV and opportunistic infections 
A study by Fergusson et al. (2009) showed similar rates of weight gain in HIV- infected and HIV-
uninfected children although HIV- infected children required a longer hospital stay. Nutrition recovery 
can be achieved and maintained in HIV-infected children, although the majority may require 
antiretroviral therapy (ART) because of low CD4 counts. 
 
Several surveys in Sub-Sahara Africa, showed a high proportion of severely malnourished children 
admitted to nutritional rehabilitation units to be HIV-infected (Kessler et al., 2000).  
In the same study by Kessler et al. (2000) in a central nutritional rehabilitation unit in Malawi, findings 
revealed a 34% HIV seroprevalence in 250 severely malnourished children older than 1 year. HIV 
infection was more associated with marasmus (62%) than kwashiorkor (21.7%). The case fatality rate 
was significantly higher for HIV-infected children, with an overall mortality of 28%.  
 
In South Africa, results of a study in three tertiary hospitals in Johannesburg are consistent with the 
findings in other parts of Africa. HIV- infected children had higher mortality risk than HIV- uninfected 
children.  The case fatality rate was 11.5%, with HIV infection as the main risk factor. Tuberculosis 
(TB) was suspected in 27 children (24%) but could only be confirmed in five (4%) (De Maayer & 
Saloojee, 2011).  
 
 
2.7 Mortality in SAM 
Case fatality rates have remained high in most hospitals in the developing countries. Case fatality rates 
can be reduced to a level of 5% with the correct treatment (Ashworth et al., 2003). In a study by 
Maitland et al. (2006) results showed a 19% case fatality, which was high compared to the 5% with 
WHO guidelines being followed.  
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2.8 Dietary management of SAM 
2.8.1 Efficacy of WHO guidelines 
Since the implementation of the WHO guidelines to treat SAM, different outcomes were recorded in 
health facilities in rural and tertiary settings. Findings by Karaolis et al. (2007) in the Eastern Cape 
revealed poor outcomes, that were attributed to staff shortage, high turnover, and lack of training, 
support and supervision for doctors and nurses. 
 
In a tertiary hospital in Bangladesh the length of stay was less than 4 weeks for 83.6% of cases and 
only 4% stayed for 31-40 days. A mean weight gain of 10.6g/kg/day was observed in children without 
oedema. The case fatality rate was 10.8% which is higher than the cut-off mark of 5% as suggested by 
the WHO. Training and support for staff members working in the paediatric wards is imperative for the 
effective implementation of the WHO guideline. (Hossain et al., 2009)  
 
Brewster (2011) critically reviewed the WHO protocol on inpatient management of severe malnutrition 
and suggested that eight changes to the protocol need to be considered in order to reduce the case-
fatalities in African hospitals.  
These suggestions include: the use of low lactose, low osmolality milk feeds during the early stage of 
treatment, especially for HIV-exposed infants and diarrhoeal cases; more cautious use of high 
carbohydrate loads (Oral Rehydration Solution, ReSomal, sucrose and 10% dextrose) during the initial 
stabilisation; more careful grading up and down of feed volumes according to the child’s responses 
during the early rehabilitation phase (Table 2.3); rapid rehydration of children in shock using Ringer’s 
lactate, as for well-nourished children, with closer monitoring for heart failure; greater use of 3
rd
-
generation cephalosporin and fluoroquinolone antibiotics to treat sepsis owing to resistant organisms; 
consider adding glutamine-arginine supplements as gut protective agents in addition to zinc and 
vitamin A; the addition of phosphate to existing potassium and magnesium supplements for those at 
risk of the refeeding syndrome; introduce better tools for diagnosing and clearer management of 
combined HIV and tuberculosis infection in infants.  
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Table 2.3: Implementation phases for the management of a child with severe malnutrition 
(WHO, 1999)  
 
Activity               Initial Treatment                                               Rehabilitation                               Follow-up 
               ________________________                         ___________________                   _____________ 
                         days1 – 2                  days3 – 7                         weeks 2 – 6                                     weeks 7 – 26 
 
Treat or prevent: 
 
Hypoglycaemia            →→→→→→→׀ 
Hypothermia                →→→→→→→׀ 
Dehydration                 →→→→→→→׀ 
 
Correct electrolyte  
imbalance                      →→→→→→→→→→→→→→→→→→→→→→→→→→→→→→→→׀ 
 
Treat infection               →→→→→→→→→→→→→→׀ 
 
Correct micronutrient  
deficiencies                    →→→→→→→→→→→→→→→→→→→→→→→→→→→→→→→→׀ 
 
                                       ׀←←←←←←← without iron →→→→→׀׀←←←←← with iron→→→→→׀ 
  
Begin feeding                →→→→→→→→→→→→→→ 
 
Increase feeding to recover lost 
weight catch-up growth”                                                          →→→→→→→→→→→→→→→→→׀ 
 
Stimulate emotional and  
Sensorial development   →→→→→→→→→→→→→→→→→→→→→→→→→→→→→→→→ 
 
Prepare for discharge                                                              →→→→→→→→→→→→→→→→→→ 
 
 
2.8.2 Ready-to-use therapeutic food (RUTF) 
RUTF is highly nutrient dense food enriched with minerals and vitamins, with a similar nutrient profile 
but greater energy and nutrient density than F100. The ready-to-use therapeutic food can be kept 
unrefrigerated for a long period of time and this is attributed to its very low water content that inhibits 
microbial growth. RUTF has a peanut butter base mixed with vegetable oil, including essential fatty 
acids and with an adequate viscosity and melting point. In contrast to F100, RUTF does not require any 
preparation before it is given to the child to eat; it can be eaten directly without adding water. It can 
also be adapted to different nutritional programmes. (Briend, 2001) 
 
The development of RUTF has alleviated some of the difficulties associated with providing a suitable 
high energy, nutrient-dense food that is safe to use in outpatient programmes (Ashworth, 2006).   
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2.8.2.1 Recommendations for use 
RUTF is recommended during the transition phase, when a new diet is introduced, preparing the patient 
for the rehabilitation phase. The number of feeds, their timing and the volume of the diet given remains 
exactly the same in the transition phase as it was in the stabilisation phase. Either RUTF or F100 can be 
used in this phase. It is recommended that children who are continuing treatment as out-patients should 
receive RUTF rather than F100. If a child is remaining in a facility during the rehabilitation phase, 
RUTF can also be given instead of F100. Children taking a RUTF should be offered as much water to 
drink as they will take during and after they have consumed the RUTF (Golden & Grellety, 2007). 
 
2.8.2.2 Research outcomes in the treatment of SAM 
Studies in Malawi have successfully used RUTF as a take-home ration in the rehabilitation phase of 
treatment of SAM. In a study by Ciliberto et al. (2005) in rural Nutrition Rehabilitation Centres 
(NRCs), 733kJ/kg/day provided from locally made RUTF,  given during rehabilitation phase of the 
treatment, produced significant rates of weight gain (3.5 vs. 2.0g/kg/day), recovery (79% vs. 46%) and 
mortality (3.0% vs. 5.4%) than the standard in-patient treatment using F100, followed by out-patient 
supplementation with a large (50kg) once off ration of corn/soya blend flour.  
 
In another study, an RUTF take home ration of 733kJ/kg/day successfully rehabilitated HIV uninfected 
severely malnourished children, after early discharge from an Nutrition Rehabilitation Units (NRU) 
providing phase 1 care according to WHO protocols. Rates of weight gain (5.2 vs. 3.1 g/kg/day) and 
the proportion of children recovering to 100% WHZ (95% vs. 78%) were significantly better in the 
RUTF groups when compared to groups receiving a large amount of energy from corn/soya blend flour 
supplied by the World Food Programme. (Manary et al., 2004) In the same study 56% of HIV positive 
children treated with RUTF also achieved 100% weight-for-height recovery (Ndekha et al., 2005). 
 
2.8.2.3 Time to recovery 
A child is considered to have recovered and be ready for discharge when he/she reaches 90% WHZ or -
1 WHZ (Ashworth et al. 2003). During the rehabilitation phase, energy dense foods are given and with 
high-energy feeding, severely malnourished children should reach their target weight for discharge 
after two to four weeks (WHO, 1999). 
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2.8.2.4 Expected growth velocity 
The WHO recommends a rate of weight gain of 10 to 15g/kg/day in children recovering from SAM in a 
hospital setting (Ashworth et al., 2003). A review by Collins et al., (2007) discussed concerns over the 
limited capacity of hospital units to treat SAM. The weaknesses of a hospital unit or centre-based 
approach in his review included:  
- Lack of skilled staff to treat the large numbers needing care, the centralised nature of hospitals 
 promotes late presentation and high opportunity costs for cares;  
- Serious risks of cross infection for immunosuppressed children with SAM and the high 
 mortality rates before and after discharge; and  
- Mortality and relapse rates both during treatment and post discharge have been high, and rates 
 of weight gain very low. 
 
Collins subsequently suggested that new approaches for the management of SAM, such as community-
based therapeutic care and extending the existing WHO inpatient protocols be implemented (Collins et 
al. 2007) 
 
Community-based therapeutic care comes as a result of hospital budgetary constraints, bed shortages, 
the reduction of hospital-acquired infections and requests by families for early discharge. 
Ashworth conducted two reviews of programmes that implemented community-based rehabilitation of 
children with SAM within health systems in non-emergency settings. Two indicators of effectiveness 
were used, case-fatality rates of <5% and average weight gain of >5g/kg/day. In the first review, six 
(22%) out of the twenty seven studies reviewed achieved effectiveness by these standards; in the 
second the success rate increases to 33% (eleven studies out of thirty three) and of the 13 published 
within the last 10 years 62% (8 studies) were effective (Ashworth, 2006). 
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According to the WHO, children with SAM should be identified and managed according to the 
following criteria (Figure 2.1) 
 
 
 
 
 
 
 
 
 
 
F 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                 
 
Figure 2.1: Summary of SAM management (WHO, 2009) 
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2.9 Integration of services 
According to the United Nation’s multilateral agencies (WHO, 2007) countries can save children’s 
lives by: 
1. Adopting and promoting national policies and programmes that: 
 Ensure that national protocols for the management of severe acute malnutrition (based, if 
 necessary, on the provision of RUTF) have a strong community-based component that 
 complements facility-based activities. 
 Achieve high coverage of interventions aimed at identifying and treating children in all parts of 
 the country and at all times of the year through effective community mobilization and active 
 case finding.  
 Provide training and support for community health workers to identify children with severe 
 acute malnutrition who need urgent treatment and to recognize those children with associated 
 complications who need urgent referral. 
 Establish adequate referral arrangements for children suffering from complicated forms of 
 severe acute malnutrition so they can receive adequate inpatient treatment. 
 Provide training for improved management of severe acute malnutrition at all levels, involving 
 an integrated approach that includes community-and facility-based components. 
 
2. Providing the resources needed for management of severe acute malnutrition, include: 
 Making RUTF available to families of children with severe acute malnutrition through a 
 network of community health workers or community-level health facilities, preferably by 
 encouraging the local food industry to produce RUTF in settings where families do not have 
 access to appropriate local foods. 
 Ensuring funding to provide free treatment of severe acute malnutrition because affected 
 families are often among the poorest. 
 
3. Integrating the management of severe acute malnutrition with other health activities, such as: 
 Preventive nutrition initiatives, including promotion of breastfeeding and appropriate 
 complementary feeding, and provision of relevant information, education and communication 
 (IEC) materials. 
 Activities related to the Integrated Management of Childhood Illness at first level health 
 facilities and at the referral level, and initiating such activities where they do not exist. 
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2.10 Summary 
A number of studies have shown high recovery rates, less relapse and increased weight gain in children 
receiving RUTF when compared to F100 (Diop et al. 2003 ; Ciliberto et al. 2005). 
The development of RUTF has alleviated difficulties associated with providing a suitable high energy, 
nutrient dense food that is safe to use in centre-based and community-based programmes (Ashworth, 
2006). In South Africa, the efficacy of RUTF in the treatment of SAM still needs to be investigated. 
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CHAPTER THREE 
METHODOLOGY 
3.1 Introduction 
The design of the study and the methodology are described in this chapter. 
 
3.2 Methods 
3.2.1 Study Design 
The study used a randomised clinically controlled trial; to measure the effectiveness of RUTF 
compared to F100 in rehabilitating children with SAM.  
 
3.2.2 Population  
The population included all clinically stable children between the age of 12 and 60 months referred to 
Clairwood hospital for treatment of malnutrition between August 2012 and September 2013 and the 
expected sample size was 60. 
 
Inclusion criteria 
Children: 
 with WHZ-score <-3SD; 
 who are clinically stable; and  
 who ate well (good appetite). 
 
 
Exclusion criteria 
Children with: 
 WHZ-score above -3SD; 
 a poor appetite; and- 
 a poor response to stimuli; and 
 had oedema. 
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3.2.3 Sampling 
Parents or legal guardians of all children who qualified according to the inclusion criteria were 
approached for informed consent and invited to allow the children to participate. Children were 
stratified according to age and gender and subsequently randomly assigned with randomised tables to 
either RUTF or F100 group. 
Children participated in the study until they recovered and recovery was defined as reaching a target 
weight of -1SD of the median NCHS/WHO reference values. When weight-for-height is used as 
admission criterion, it is advisable to discharge children at a weight-for-height of -1SD of the median 
NCHS/WHO reference value (WHO, 1999). 
 
Body weight of the children was measured weekly and MUAC and height measured every 2 weeks. 
WHO standards recommend a cut-off of 11.5cm for MUAC (Table 3.1) to identify infants and children 
with SAM (WHO, 2009). The primary outcome of the study was recovery, with rates of weight and 
height gain as secondary outcomes. 
 
Table 3.1: Criteria for SAM in children aged 6-60 months (WHO , 2009) 
 
 
3.2.4 Sample Size 
The expected sample size was 60 or more children. A total sample size of 35 children was obtained 
from those that were referred by the surrounding hospitals from Ethekwini district in KwaZulu-Natal to 
Clairwood hospital. The expected sample size was not achieved because children were not forced to eat 
either RUTF or F100; only children who were willing to participate were enrolled in the study. This 
will be discussed in more detail in the limitations of the study. 
 
 
 
Measure Cut-off Indicator 
Weight-for-height <-3 SD Severe wasting 
MUAC <11.5cm Severe wasting 
Bilateral oedema Clinical sign  
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3.3 Procedures and Interventions 
3.3.1 Procedures 
3.3.1.1 Monitoring Sheet 
Quantitative data collection methods often employ measuring instruments such as structured 
observation schedules, structured interviewing schedules, questionnaires, checklists, indexes and scales 
(de Vos et al., 2011). Data in this study was collected and weekly measurements collated on a 
monitoring sheet before transferring to a spread sheet. A monitoring sheet (Addendum D) initially 
developed by the HIV&AIDS Research unit, NMMU for a similar intervention study was adapted by 
the researcher for this study. The researcher completed and coded the standardised datasheet. 
Information was recorded on the datasheet from the time of admission (baseline), then weekly until the 
end of six weeks. The datasheet included anthropometric measurements (weight, height and MUAC). 
 
3.3.2 Variables 
3.3.2.1 Weight 
Children were weighed using a calibrated Secca Paediatric scale with accuracy to the nearest 10g 
according to standardised procedures. All children were weighed without a nappy, clothing and shoes. 
Weekly weight changes were recorded over a period of four to six weeks, and recorded as the amount 
gained or lost in g/kg/day. The scale was placed on a hard surface; the child was placed in the middle 
and kept still until the measurement was taken (Gibson, 2005). 
 
3.3.2.2 Height 
A measuring mat with an accuracy of 0.1cm was used to take height measurements. The measuring mat 
was placed on a flat surface in order to obtain accurate measurements. The researcher and a trained 
nurse worked together in taking accurate height measurements every two weeks to record changes in 
height. The measurement was taken if the head was level with the headboard and the end of the 
measuring mat or board was against a flexed heel (Gibson, 2005). Three height measures were taken 
and the average was calculated and recorded. 
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3.3.2.3 MUAC 
 
The MUAC was measured by the researcher using a MUAC tape with accuracy to the nearest 1mm. 
The MUAC was taken every two weeks. The measuring tape fitted snuggly around the left arm, 
without making a dent in the upper arm (Gibson, 2005). The arm was kept in a relaxed position along 
the side of the body. 
 
3.3.2.4 Rate of weight gain 
The rate of weight gain was calculated using the following formula:  
   Weight gain in g/kg/day =   (W1 – W2) x 1000 
             ---------------------------------------------- 
             (W1 x number of days from W1 to W2) 
 
Where: W1 = initial weight in kg; W2 = weight in kg on the day of calculation. For the purpose of the 
study poor growth velocity referred to < 5g/kg/day; moderate growth referred to 5 to 10g/kg/day and 
good growth referred to > 10g/kg/day (Ashworth et al., 2003). 
              
3.3.2.5 Intervention 
Children were assigned into two intervention groups (Table 3.2). The first group received F100 in 
quantities sufficient to meet their nutrient requirements for full catch-up growth (175 kcal-200 kcal as 
recommended by the WHO for the period of four to six weeks or until excluded). 
 
The second group received RUTF in a quantity sufficient to meet their nutrient requirements for catch-
up growth, 175kcal-200kcal, for the period of four to six weeks. Appetite was tested, and any child who 
passed the test was started on RUTF. In order to pass the appetite test children who weighed between 
4kg to 10kg were expected to take 25% to 75% respectively of a sachet of RUTF (Golden & Grellety, 
2006). The trial was not blind as F100 has a completely different appearance from RUTF. 
 
Children in the F100 group were given 3 hourly feeds. The feeds were given in accordance with the 
WHO protocol (Appendix 8; range of volumes for free feeding with F100 for children of different 
weights. Addendum G). The amount of feeds for each child was guided by the weight of the child and 
calculated from the given range in Appendix 8. The total volume of feeds depended on how much feed 
the child tolerated. The feeds were given by a nurse or the caregiver in addition to the hospital diet.  
In the RUTF group, RUTF was given in proportion to a child’s weight in accordance with the WHO 
protocol (Addendum G). The FAO formula (100ml of F100 = 18.5g of RUTF) was used to calculate 
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and convert the volume in millimetres to grams (Kimani & Sharif, 2009). This ensured that the children 
in the F100 group received the same amount of energy as children in the RUTF group. 
 
The RUTF amount for each child were divided into two and mixed into their morning and evening 
porridge. The younger children were fed by a nurse or a caregiver and the older children who were able 
to feed themselves did so under supervision of a nurse. 
 
RUTF and F100 were manufactured by local manufacturers. The manufacturer’s values for energy and 
nutrient contents of RUTF and F100 were used for analysis. Table shows that RUTF is more nutrient 
dense than F100.  
  
Table 3.2 Comparison of the nutritional composition of RUTF and F100 
 
 *RUTF per 100g *F100 per 100ml 
(Reconstituted) 
Energy 523 Kcal 100kcal 
Protein 13.4g 2.9 g 
Lactose 10.52g 4.2 g 
Potassium 787mg 5.9mmol 
Sodium 192.8mg 1.9mmol 
Magnesium 95mg 0.73mmol 
Zinc 12.3mg 2.3mg 
Copper 1.5mg 0.25mg 
     *RUTF specifications (Diva Nutritional Products insert) 
     *F100 specifications (Ashworth et al., 2003)  
 
3.4 Pilot Study 
A pilot study was conducted at Clairwood Hospital that included three severely malnourished children 
admitted to the hospital. The monitoring sheet was tested by the researcher using the same 
measurements that was used in the main study. The pilot study revealed no problems with the 
monitoring sheet and therefore it was not adapted. No problems were experienced during the 
completion of the datasheet, thus requiring no other changes. 
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3.5 Statistical Analysis 
Data was recorded on an Excel spreadsheet and analysed by means of the Statistica software package. 
Data from the two treatment groups were compared. Frequencies and percentages were used to 
summarise the categorical data. Means and standard deviations were used to summarise quantitative 
variables. Comparison of means was done using the Mann-Whitney U test to determine statistical 
significance and a p-value <0.05 used to indicate statistical significance. 
 
3.6 Ethical Consideration 
Ethical approval for the study was obtained from the Research Ethics Committee (REC) – Human, 
Nelson Mandela Metropolitan University (H12-RTI-HIV-005). Approval for the research at Clairwood 
hospital was obtained from the Chief Executive Officer (CEO) of Clairwood hospital, the Department 
of Health KwaZulu-Natal Research committee and the Nutrition Director from the Department of 
Health KwaZulu-Natal (Addendum F) 
 
Informed consent (Addendum B) was obtained from the participants’ legal guardian in their language 
of choice before commencement of the study. 
 
Legal guardians were approached by the researcher at Clairwood hospital who explained that 
participation is voluntary and that refusal will not impact on the rest of the child’s treatment in any 
way.  
 
The name of the child was included in the datasheet to facilitate follow-up during the study. On 
completion of the data collection, the datasheet was given a number for coding and data analysis and 
the name of the child was not used in data analysis in order to maintain confidentiality. 
 
Interventions in this study formed part of management of SAM at Clairwood hospital prior to the 
research. The referring hospitals used the same treatments in the management of these children before 
being referred to Clairwood hospital for rehabilitation. 
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3.7 Reliability 
The researcher used standardised techniques as recommended by Gibson (2005). The equipment used 
was of high quality and was regularly calibrated. The nurse who assisted in taking anthropometric 
measurements was trained in standardised techniques. The researcher coded the monitoring sheet to 
ensure reliability of the data. 
  
3.8 Validity 
The monitoring sheet was designed to record all the information required to reflect the aims and 
objectives of the study. Recording was done by the researcher only. Valid measures were taken 
according to the objectives of the study. 
 
3.9 Limitations 
Children were fed by nurses, mothers or caregivers, and the amounts of RUTF and F100 taken by each 
child were recorded by the nurse. There was no full observation or plate wasting done by the researcher 
to confirm the total amounts of RUTF or F100 eaten by each child. Children were not forced to eat 
RUTF or F100; children who refused to eat these supplements were given an alternative and they were 
not included in the study. This decreased the number of children participating in this study by 7 
children.   
The number of referrals from the surrounding hospitals to Clairwood hospital for nutrition 
rehabilitation impacted on the total number of participants. Most hospitals in Ethekwini district started 
using the new guidelines for SAM management. The children were managed from admission until 
discharge to follow-up phase without referring to Clairwood hospital for rehabilitation.  
The original sample size of 60 participants was reduced to 35 due to the limitations delineated above. 
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CHAPTER FOUR 
 RESULTS  
4.1 Introduction 
Research results regarding demographic information, rate of weight gain, timeframe to recovery, 
changes in height and MUAC, morbidity and mortality, and retention on the program will be reported 
in this chapter. 
4.2 Demographics  
Of the total number of children (n=35) that participated in the study; one defaulted after two weeks and 
was not included in the final data analysis, 55.9% (n=19) were male and 44.1% (n=15) were female 
(Table 4.1). Ages ranged from 12 to 60 months, with the majority of the children between 12 and18 
months 55.9% (n=19), (Table 4.2). The mean age was 22.32 months (±12.48 SD).  
    Table 4.1 Gender of children (N=34) 
Gender n % 
Boys 19 55.9 
Girls 15 44.1 
Total 34 100 
 
    Table 4.2 Age of children (N=34) 
Age (months) N % 
12 – 18 19 55.9 
19 – 24 7 20.6 
25 – 30 3 8.8 
31 – 36 0 0 
37 – 42 0 0 
43 – 48 3 8.8 
49 – 54 2 5.9 
Total 34 100 
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4.3 Description of sample 
Children were stratified and randomly allocated to the RUTF and F100 group. The information in 
Table 4.3 and Table 4.4 shows the gender and the age of children included in the RUTF and F100 
intervention groups.  
Although the majority of the boys were in the F100 group 52.6% (n=10) and only 47% (n=9) in the 
RUTF group, no significant difference could be demonstrated between the groups. Of the 15 girls 
included in the study 53% (n=8) were in the RUTF group and 47% (n=7) in the F100 group. Of the 
children between 12 to 36 months, 44.8% (n=13) were in the RUTF group and 55.2% (n=16) were in 
the F100 group. As no statistical differences could be demonstrated, for the purposes of data analysis 
the two groups were assumed to be similar. 
 
    Table 4.3 Gender distribution between groups 
Gender 
RUTF 
(N=17) 
F100 
(N=17) 
Total 
 
n % n % n % 
Boys 9 47.4 10 52.6 19 100 
Girls 8 53.3 7 46.7 15 100 
 
   Table 4.4 Age (months) distribution between groups 
Age 
(months 
RUTF 
(N=17) 
F100 
(N=17) 
Total 
 
n % n % n % 
12 – 36 13 44.8 16 55.2 29 100 
36 – 60 4 80.0 1 20.0 5 100 
 
A large percentage of children that participated in the study were HIV-infected, 76.5% (n=13) in the 
F100 group and 70.5% (n=12) in the RUTF group. Out of 34 children, 11.8% (n=2) and 17.6% (n=3) in 
the RUTF and F100 groups respectively, had Tuberculosis (TB). Only one child had Foetal Alcohol 
Syndrome (FAS). A smaller percentage of children from both groups had no disease (Table 4.5). 
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       Table 4.5 Diseases affecting the children 
 
 
 
 
 
 
 
 
4.4 Clinical Signs on admission 
The common clinical signs on admission for the children that participated in the study were; dry skin; 
loose skin around the arm, thigh and buttocks area; thin sparse hair; and marasmus. 55.8% of children 
in the RUTF group and 57% in the F100 group presented with these clinical signs. 
 
4.5 Symptoms  
Fever and/or cough were reported in 11.8% (n=2) children in the RUTF group and 23.5% (n=4) 
children in the F100 group during the six week intervention period. Only 5.88% (n=2) children 
experienced diarrhoea, one from the RUTF group and one from the RUTF group. Vomiting was 
experienced by both groups; 11.8% (n=4) children in the RUTF group and 11.8% (n=4) children in the 
F100 group. 
 
4.6 Morbidity and Mortality 
Out of 34 children that participated in the study, only one child died as a result of diarrhoea and HIV 
complications. The child was in the F100 group.  
 
 
 
Co-morbid diseases 
and other disease 
RUTF 
(N=17)                   
F100 
(N =17)                  
TB 2 11.8% 3 17.6% 
HIV/AIDS 12 70.5% 13 76.5% 
FAS 1 5.9% 0 0% 
No disease 2 11.8% 1 5.9% 
Total 17 100% 17 100% 
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4.7 Rate of weight gain 
The mean growth velocity was 7.77g/kg/day (±2.72SD) in the RUTF group and 6.11g/kg/day (± 
4.87SD) in the F100 group. There was no significant difference between groups (P=0.46). Both groups 
therefore experienced moderate growth velocity (Table 4.6). 
Table 4.7 and Figure 4.1, reflects the rate at which weight was gained by children in the RUTF and 
F100 intervention groups.  
 
     Table 4.6 Growth Velocity in intervention (g/kg/day) 
Groups  Mean SD P-value  
RUTF (n=17) 7.77  2.72 
0.46 
F100 (n=17) 6.11 4.87 
 
 
     Table 4.7 Growth velocity between groups 
 
 
 
 
 
 
  
Groups Growth velocity  Total 
<5g/kg/day 
(poor) 
5-10g/kg/day 
(moderate) 
>10g/kg/day 
(good) 
n % N % N % 
RUTF 
(n=17) 
2 11.8 14 82.4 1 5.8 100% 
F100 
(N=17) 
5 29.4 10 58.8 2 11.8 100% 
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*poor (<5 g/kg/d); moderate (5-10 g/kg/d); good (>10 g/kg/d), (Ashworth et al 2003) 
Figure 4.1 Weight gain in children between groups 
 
 
 
Figure 4.2 Growth velocity between groups 
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 4.8 Time-frame to recovery 
41.2% (n=7) of children in the RUTF group recovered within 3 weeks (21 days), and only 17.7% (n=3) 
of children in the F100 group recovered within 3 weeks (Table 4.8 and Figure 4.3). 11.8% (n=2) never 
reached the target weight in the RUTF and 35.3% (n=6) in the F100 group. A total of 88.2% (n=15) of 
children recovered in the RUTF group within the 6 week intervention period and 64.7% (n=110 in the 
F100 group (Table 4.9). 
 
      Table 4.8 Recovery rates between RUTF and F100 group 
WHZ ≥ -1 RUTF 
n                         % 
F100 
n                        % 
Week 2 1 5.8 1 5.8 
Week 3 7 41.2 3 17.7 
Week 4 4 23.5 3 17.7 
Week 6 3 17.7 4 23.5 
Never 
recovered to 
target weight 
2 11.8 6 35.3 
Total 17 100 17 100 
 
       Table: 4.9 Overall recovery in the RUTF group and F100 group 
WHZ ≥ -1 
RUTF 
n                      % 
F100 
n                     % 
Reached target 
weight 
15 88.2 11 64.7 
Never reached 
target weight 
2 11.8 6 35.3 
Total 17 100 17 100 
 
  
43 
 
 
Figure 4.3 WHZ score ≥-1  
 
4.9 Height and MUAC 
 4.9.1 Height 
Of the 34 children participating in the study, no changes in height were observed within both the RUTF 
and F100 groups in the six week period.  
  
4.9.2 MUAC 
91.2% (n=31) children had a MUAC of >11.5 cm after 6 weeks of rehabilitation with RUTF and F100. 
Only 2.9% (n=1) child from the RUTF group and only 11.8% (n=2) children from the F100 group did 
not reach the MUAC of >11.5cm after 6 weeks of intervention (Table 4.10). 
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    Table 4.10 MUAC CHANGES 
RUTF F100 
BASELINE 
MUAC 
(cm) 
MUAC 
AFTER 6 
WEEKS 
(cm) 
BASELINE 
MUAC 
(cm) 
MUAC 
AFTER 6 
WEEKS 
(cm) 
11.2 12.9 9.8 12.5 
9.2 12.5 9.5 12.0 
9.7 10.9 10.4 12.3 
11.1 13.3 10.1 11.9 
9.8 12.9 9.5 10.9 
11.1 12.8 11.0 13.7 
11.3 13.5 11.2 13.1 
9.8 12.8 11.5 13.6 
11.0 12.7 10.5 Died 
10.8 13.3 11.0 13.6 
11.3 13.9 11.2 13.4 
10.9 14.1 11.3 13.2 
11.0 12.3 11.2 12.4 
11.0 13.8 10.9 12.5 
11.0 13.5 11.0 12.5 
11.2 13.6 11.0 13.5 
10.8 12.8 11.0 12.6 
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4.10 SUMMARY 
The majority of children in this study were 12 to18 months, with boys in the majority. Both groups had 
a large percentage of HIV-infected children; 70% in the RUTF group and 76% in the F100 group with 
TB infection present in some of the children. The prevalence of fever, diarrhoea, and cough was low in 
both groups. One child died as a result of diarrhoea and HIV related complications. Growth velocity 
was 7.77g/kg/day in the RUTF group and 6.11g/kg/day in the F100 group with no significant difference 
between groups (P = 0.46). The majority of children recovered within 21 days in the RUTF group 
while the majority of children recovered after 6 weeks in the F100 group. There were no changes in 
height during the rehabilitation of these children. MUAC changes were observed with 92% having 
MUAC of >11.5cm after 6 weeks intervention with RUTF and F100. 
Although differences between groups were not significant with regard to growth velocity, faster 
recovery of clinically stable children with SAM was possible at Clairwood hospital with RUTF rather 
than F100. 
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CHAPTER FIVE 
DISCUSSION, CONCLUSION, AND RECOMMENDATIONS 
5.1 Introduction  
This chapter deals with the interpretation of results from the previous chapter. The results will be 
discussed and compared with relevant studies of the similar nature. 
 
5.1.1 Demographic information 
The results in this study show that both genders were represented. All were between the ages of 12 to 
60 months. There were more boys than girls and 55.9% of the sample had an age between 12 to 18 
months. A study by Madondo et al. (2012) in children less than 5 years admitted to Nyangabgwe 
referral hospital in Botswana showed a high prevalence of severe malnutrition in the age group 12 to 23 
months, of which 82.5% were boys. Berkley et al. (2005) assessed hospitalized children in rural Kenya, 
and found that severe wasting was more common among boys than girls. A study on improving clinical 
management of severely malnourished children in rural hospitals in South Africa showed that 41% of 
children with SAM were in the age group 18 to 24 months out of a wide range of six weeks to 4 years 
(Pouane et al., 2004). Younger children and especially boys seemed to be at higher risk to develop 
SAM in Southern Africa. 
 
5.1.2 HIV and TB prevalence 
In sub-Saharan Africa, an increasing percentage of children requiring hospitalisation are those who are 
HIV-infected or HIV exposed, often co-infected with TB (Heinkens et al., 2008). 
The results of this study showed a very high prevalence of HIV-infected children, more than 70% in 
both groups. Findings also revealed a low prevalence of TB in both groups. Although Dramowski et al. 
(2011) reported a high prevalence of HIV-infected children admitted to Chris Baragwanath Hospital’s 
general paediatric wards between 1 October 2007 and December 2007 with 29.5% of admissions were 
HIV infected, HIV prevalence in Clairwood hospital among SAM cases in this study were higher.  
 
5.1.3 Clinical signs and symptoms 
The results suggest that the most common symptom experienced by children in this study was 
vomiting; although this symptom only occurred in few children - therefore it is unlikely that it 
influenced the intake of the supplements or the outcome of the study. Results also showed that very few 
children experienced diarrhoea, in both the RUTF and F100 group. Children had fewer symptoms of 
infections during the intervention period. And this may be attributed to the fact that all HIV-infected 
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children, those who were not on ART were started on ART and all TB infected children were initiated 
on TB treatment.  
 
Common features such as thin sparse hair, dry skin, and loose skin on the arm, thigh and buttock area, 
are marasmic features that were observed in this study. 
 
5.1.4 Morbidity and mortality 
The only death in this study was due to HIV complications and diarrhoea. HIV/AIDS and diarrhoeal 
infections have been associated with an increased risk of mortality in children with SAM receiving 
treatment in inpatient units (Heikens et al., 2008). As all the children, apart from one recovered from 
SAM, and clinical symptoms were controlled, this study suggests that it is possible to control morbidity 
and mortality in a clinically controlled environment in clinically stable children with SAM. 
 
5.1.5 Rate of weight gain 
In this study the results suggest that RUTF promotes better weight gain than F100 during rehabilitation 
phase of the management of SAM although not statistical significant. A mean weight gain velocity of 
7.7g/kg/day was observed in the RUTF group 6.11g/kg/day in the RUTF group. 
A lower rate of weight gain in this study was observed when compared to other studies (Diop et al., 
2003) where better outcomes with RUTF in the inpatient treatment of SAM were reported with greater 
rates of weight gain (15.1g/kg/day) observed. A review by Teferi et al. (2010) on treatment outcomes 
of children with SAM admitted to therapeutic feeding centres in Southern Region of Ethiopia showed 
an average rate of weight gain of 8-12g/kg/day in children with SAM treated with F100. Studies have 
also shown improved outcomes among ART-treated HIV-infected children who received RUTF 
(Sunguya et al., 2012). 
 
5.1.6 Time to recovery  
This study showed that children on RUTF were able to achieve higher rates of recovery than children 
on F100 during the 6 week period of rehabilitating children with SAM at Clairwood hospital. Recovery 
was achieved in the third week of intervention with RUTF. Children with SAM that are fed with high-
energy foods were able to reach their target weight for discharge after 2-4 weeks (WHO, 1999). The 
duration of hospital stay at Clairwood hospital was about 8 weeks or longer, and prolonged 
hospitalization can be costly. The results of this study suggest that children with SAM may be fully 
rehabilitated within three weeks of using RUTF, and this will result in a shorter hospital stay and cost 
savings. The cost per patient per day at Clairwood hospital was R965.50 in the second quarter of 2013. 
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With RUTF, hospital stay can be reduced by five weeks and a total cost saving of about R33 792.50 per 
patient is possible.  
 
5.1.7 MUAC   
Children with a MUAC of less than 11.5cm have a highly elevated risk of death compared to those 
above 11.5cm (WHO, 2009). In this study, results showed that the majority of children had MUAC 
measurements of ≤11.5cm to above, and this was associated with of weight gain. The one child that 
died in this study had a MUAC of 9.8cm. Early identification and recognition of SAM among children 
is important for the treatment of SAM and for lowering case fatality rates.   
 
 
5.2 CONCLUSION 
In conclusion, RUTF resulted in better rates of recovery and can be used efficiently in rehabilitating 
children with SAM in a supervised facility setting. RUTF is energy dense, convenient and safe to use, 
and it does not require preparation. The shortened in-patient stay will benefit the hospital by reducing 
costs in rehabilitating SAM children. A follow-up study should be done with a larger sample, in order 
to establish if there is any significant difference between groups. 
 
 
5.3 RECOMMENDATIONS 
 
RUTF for rehabilitating children with SAM 
Based on the findings, the researcher recommends that RUTF be used in rehabilitating children with 
SAM in Clairwood Hospital, if accepted by the children. Hospital stay can be reduced by five weeks 
implicating a saving of R33 792.50 per patient. It should be taken into account that the risks of bacterial 
contamination are lower with RUTF due to its very low water content and the fact that, children with 
SAM have a higher risk of death due to diarrhoea (Briend, 2001; Irena et al., 2011). RUTF does not 
require preparation and it has been established that, poor outcomes in the management of SAM were 
associated with staff shortages (Karaolis et al., 2007). 
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Establish rehabilitation units or centres 
All clinically stable children with SAM should be referred to rehabilitation units for rehabilitation and 
not managed as inpatients; inpatient should be reserved for those with complications. During the 
rehabilitation phase catch-up growth must be achieved as well rapid weight gain.  Energy dense foods 
may be used in this setting because children are stable and have a good appetite. 
 
Training of staff 
Training for staff should be provided at all levels in order to improve management of SAM. Studies 
have shown that lack of training is associated with poor outcomes and therefore training of staff is 
important in order to achieve better outcomes (Karaolis et al., 2007). Staff should be trained on how to 
identify children with and how to implement the guidelines for the management of SAM.  
   
Community-based management of SAM 
An integrated approach that includes facility and community-based management of SAM should be 
established, aimed at identifying and treating children in all parts of the country and at all times of the 
year through effective community mobilisation and active case finding.  
 
Follow-up study 
A follow-up study with a larger sample should be done, in order to establish if there is any significant 
difference between the groups. It is also suggested that children be followed up in order to establish 
relapse rates when treated with different nutrition supplements. 
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ADDENDUM A  
 STEPS FOR THE MANAGEMENT OF SEVERE MALNUTRITION (Ashworth et al., 2003) 
Step 1. Treat/prevent hypoglycaemia 
 
Hypoglycaemia and hypothermia usually occur together and are signs of infection. Check for hypoglycaemia whenever hypothermia 
(axillary <35.0oC; rectal<35.5oC) is found. Frequent feeding is important in preventing both conditions. 
Treatment: 
If the child is conscious and dextrostix shows <3mmol/l or 54mg/dl give: 
• 50 ml bolus of 10% glucose or 10% sucrose solution (1 rounded teaspoon of sugar in 3.5 tablespoons water), orally or by nasogastric 
(NG) tube. Then feed starter F-75 (see step 7) every 30 min. for two hours (giving one quarter of the two-hourly feed each time) 
• antibiotics (see step 5) 
• two-hourly feeds, day and night (see step 7) 
If the child is unconscious, lethargic or convulsing give: 
• IV sterile 10% glucose (5ml/kg), followed by 50ml of 10% glucose or sucrose by Ng tube. Then give starter F-75 as above 
• antibiotics 
• two-hourly feeds, day and night 
Monitor: 
• blood glucose: if this was low, repeat dextrostix taking blood from finger or heel, after two hours. Once treated, most children stabilise 
within 30 min. If blood glucose falls to <3 mmol/l give a further 50mlbolus of 10% glucose or sucrose solution, and continue feeding 
every 30 min. until stable 
• rectal temperature: if this falls to <35.5oC, repeat dextrostix 
• level of consciousness: if this deteriorates, repeat dextrostix 
Prevention: 
• feed two-hourly, start straightaway (see step 7) or if necessary, rehydrate first 
• always give feeds throughout the night 
Step 2. Treat/prevent hypothermia 
Treatment: 
If the axillary temperature is <35.0oC, take the rectal temperature using a low reading thermometer. 
If the rectal temperature is <35.5oC (<95.9oF): 
• feed straightaway (or start rehydration if needed) 
• re-warm the child: either clothe the child (including head), cover with a warmed blanket and place a heater or lamp nearby (do not use a 
hot water bottle), or put the child on the mother’s bare chest (skin to skin) and cover them 
• give antibiotics (see step 5) 
Monitor: 
• body temperature: during re warming take rectal temperature two hourly until it rises to >36.5oC (take half-hourly if heater is used) 
• ensure the child is covered at all times, especially at night 
• feel for warmth 
• blood glucose level: check for hypoglycaemia whenever 
hypothermia is found 
Prevention: 
• feed two-hourly, start straightaway (see step 7) 
• always give feeds throughout the day and night 
• keep covered and away from draughts 
• keep the child dry, change wet nappies, clothes and bedding 
• avoid exposure (e.g. bathing, prolonged medical examinations) 
• let child sleep with mother/carer at night for warmth 
 
 
 
Step 3. 
 
 
 
Treat/ prevent dehydration 
 
Note: Low blood volume can coexist with oedema. Do not use the IV route for rehydration except in cases of shock and then do so with 
care, infusing slowly to avoid flooding the circulation and overloading the heart 
Treatment: 
The standard oral rehydration salts solution (90 mmol sodium/l) contains too much sodium and too little potassium for severely 
malnourished children. 
Instead give special Rehydration Solution for Malnutrition (ReSoMal).  
It is difficult to estimate dehydration status in a severely malnourished child using clinical signs alone. So assume all children with watery 
diarrhoea may have dehydration and give: 
• ReSoMal 5 ml/kg every 30 min. for two hours, orally or by nasogastric tube, then 
• 5-10 ml/kg/h for next 4-10 hours: the exact amount to be given should be determined by how much the child wants, and stool loss and 
vomiting. Replace the ReSoMal doses at 4, 6, 8 and 10 hours with 
F-75 if rehydration is continuing at these times, then 
• continue feeding starter F-75  
During treatment, rapid respiration and pulse rates should slow down and the child should begin to pass urine. Monitor progress of 
rehydration: 
Observe half-hourly for two hours, then hourly for the next 6-12 hours, recording: 
• pulse rate 
• respiratory rate 
• urine frequency 
• stool/vomit frequency 
Return of tears, moist mouth, eyes and fontanels appearing less sunken, and improved skin turgor, are also signs that rehydration is 
proceeding. It should be noted that many severely malnourished children will not show these changes even when fully rehydrated. 
Continuing rapid breathing and pulse during rehydration suggest coexisting infection over hydration. Signs of excess fluid (over 
hydration) are increasing respiratory rate and pulse rate, increasing oedema and puffy eyelids. If these signs occur, stop fluids 
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immediately and reassess after one hour. 
Prevention: 
To prevent dehydration when a child has continuing watery diarrhoea: 
• keep feeding with starter F-75  
• replace approximate volume of stool losses with ReSoMal. As a guide give 50-100 ml after each watery stool. (Note: it is common for 
malnourished children to pass many small unformed stools: these 
should not be confused with profuse watery stools and do not require 
fluid replacement) 
• if the child is breastfed, encourage to continue 
 
Step 4. Correct electrolyte imbalance 
All severely malnourished children have excess body sodium even though plasma sodium may be low (giving high sodium loads will 
kill). Deficiencies of potassium and magnesium are also present and may take at least two weeks to correct. Oedema is partly due to these 
imbalances. Do NOT treat oedema with a diuretic. 
Give: 
• extra potassium 3-4 mmol/kg/d 
• extra magnesium 0.4-0.6 mmol/kg/d 
• when rehydrating, give low sodium rehydration fluid (e.g. ReSoMal) 
• prepare food without salt 
The extra potassium and magnesium can be prepared in a liquid form and added directly to feeds during preparation.  Adding 20 ml of 
this solution to 1 litre of feed will supply the extra potassium and magnesium required. The solution can also be added to ReSoMal. 
 
Step 5. Treat/prevent infection 
In severe malnutrition the usual signs of infection, such as fever, are often absent, and infections are often hidden. 
Therefore give routinely on admission: 
• broad-spectrum antibiotic(s) AND 
• measles vaccine if child is > 6m and not immunised (delay if the child is in shock) 
Note: Some experts routinely give, in addition to broad-spectrum antibiotics, metronidazole (7.5 mg/kg 8-hourly for 7 days) to hasten 
repair of the intestinal mucosa and reduce the risk of oxidative damage and systemic infection arising from the overgrowth of anaerobic 
bacteria in the small intestine. 
Choice of broad-spectrum antibiotics:  
a) if the child appears to have no complications give:  
• Co-trimoxazole 5 ml paediatric suspension orally twice daily for 5 days (2.5 ml if weight <6 kg). (5 ml is equivalent to 40 mg 
TMP+200mg SMX). 
OR 
b) if the child is severely ill (apathetic, lethargic) or has complications 
(hypoglycaemia; hypothermia; broken skin; respiratory tract or urinary tract infection) give: 
• Ampicillin 50mg/kg IM/IV 6-hourly for 2 days, then oral amoxycillin 15mg/kg 8-hourly for 5 days, or if amoxycillin is not available, 
continue with ampicillin but give orally 50mg/kg 6-hourly 
AND 
• Gentamicin 7.5 mg/kg IM/IV once daily for 7 days 
If the child fails to improve clinically within 48 hours, ADD: 
• Chloramphenicol 25 mg/kg IM/IV 8-hourly for 5 days 
Where specific infections are identified, ADD: 
• specific antibiotics if appropriate 
• anti malarial treatment if the child has a positive blood film for malaria parasites 
If anorexia persists after 5 days of antibiotic treatment, complete a full 10- day course. If anorexia still persists, reassess the child fully, 
checking for sites of infection and potentially resistant organisms, and ensure that vitamin and mineral supplements have been correctly 
given. 
 
Step 6. Correct micronutrient deficiencies 
All severely malnourished children have vitamin and mineral deficiencies. 
Although anaemia is common, do NOT give iron initially but wait until the child has a good appetite and starts gaining weight (usually 
by the second week), as giving iron can make infections worse. 
Give: 
• Vitamin A orally on Day 1 (for age >12 months, give 200,000 IU; for age 6-12 months, give 100,000 IU; for age 0-5 months, give 
50,000 
IU) unless there is definite evidence that a dose has been given in the last month 
Give daily for at least 2 weeks: 
• Multivitamin supplement 
• Folic acid 1 mg/d (give 5 mg on Day 1) 
• Zinc 2 mg/kg/d 
• Copper 0.3 mg/kg/d 
• Iron 3 mg/kg/d but only when gaining weight 
 
Step 7.  Start cautious feeding 
In the stabilisation phase a cautious approach is required because of the child’s fragile physiological state and reduced homeostatic 
capacity. Feeding should be started as soon as possible after admission and should be designed to provide just sufficient energy and 
protein to maintain basic physiological processes. The essential features of feeding in the stabilisation phase are: 
• small, frequent feeds of low osmolarity and low lactose 
• oral or nasogastric (NG) feeds (never parenteral preparations) 
• 100 kcal/kg/d 
• 1-1.5 g protein/kg/d 
• 130 ml/kg/d of fluid (100 ml/kg/d if the child has severe oedema) 
• if the child is breastfed, encourage to continue breastfeeding but give the prescribed amounts of starter formula to make sure the child’s 
needs are met. 
The suggested starter formula and feeding schedules are designed to meet these targets. 
Milk-based formulas such as starter F-75 containing 75 kcal/100 ml and 0.9g protein/100 ml will be satisfactory for most children give 
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from a cup. Very weak children may be fed by spoon, dropper or syringe. 
A recommended schedule in which volume is gradually increased, and feeding frequency gradually decreased is: 
Days Frequency Vol/kg/feed Vol/kg/d 
1-2 2-hourly 11 ml 130 ml 
3-5 3-hourly 16 ml 130 ml 
6-7+ 4-hourly 22 ml 130 ml 
For children with a good appetite and no oedema, this schedule can be completed in 2-3 days (e.g. 24 hours at each level).  
 
Step 8. Achieve catch-up growth 
In the rehabilitation phase a vigorous approach to feeding is required to achieve very high intakes and rapid weight gain of >10 g 
gain/kg/d. The 
recommended milk-based F-100 contains 100 kcal and 2.9 g protein/100 ml 
Modified porridges or modified family food scan be used provided they have comparable energy and protein concentrations. 
Readiness to enter the rehabilitation phase is signalled by a return of appetite, usually about one week after admission. A gradual 
transition is recommended to avoid the risk of heart failure which can occur if children suddenly consume huge amounts. 
To change from starter to catch-up formula: 
• replace starter F-75 with the same amount of catch-up formula F-100 for 48 hours then, 
• increase each successive feed by 10 ml until some feed remains uneaten. The point when some remains unconsumed is likely to occur 
when intakes reach about 30 ml/kg/feed (200 ml/kg/d).  
Monitor during the transition for signs of heart failure: 
• respiratory rate 
• pulse rate 
If respirations increase by 5 or more breaths/min and pulse by 25 or more beats/min for two successive 4-hourly readings, reduce the 
volume per feed (give 4-hourly F-100 at 16 ml/kg/feed for 24 hours, then 19 ml/kg/feed for 24 hours, then 22 ml/kg/feed for 48 hours, 
then increase each feed by 
10 ml as above). 
After the transition give: 
• frequent feeds (at least 4-hourly) of unlimited amounts of a catch-up formula 
• 150-220 kcal/kg/d 
• 4-6 g protein/kg/d 
• if the child is breastfed, encourage to continue (Note: breast milk does not have sufficient energy and protein to support rapid catch-up 
growth). 
Monitor progress after the transition by assessing the rate of weight gain. 
Step 9. Provide sensory stimulation and emotional support 
In severe malnutrition there is delayed mental and behavioural development. 
Provide: 
• tender loving care 
• a cheerful, stimulating environment 
• structured play therapy 15-30 min/d 
• physical activity as soon as the child is well enough 
• maternal involvement when possible (e.g. comforting, feeding, bathing, 
play) 
 
Step 10. Prepare for follow-up after recovery 
A child who is 90% weight-for-length (equivalent to -1SD) can be considered to have recovered. The child is still likely to have a low 
weight-for-age because of stunting. Good feeding practices and sensory stimulation should be continued at home. Show parent or carer 
how to: 
• feed frequently with energy- and nutrient-dense foods 
• give structured play therapy 
Advise parent or carer to: 
• bring child back for regular follow-up checks 
• ensure booster immunizations are given 
• ensure vitamin A is given every six months 
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ADDENDUM B 
CONSENT FORM        H12-RTI-HIV-005 
 
I, the undersigned, ___________________________________________________ (Parent or legal 
Guardian) of_________________________________________________________(Name of Child) 
Give consent that ______________________________ (name of child) may participate in the study carried 
out by Anele Nomvete, dietician at Clairwood hospital. It was explained to me that: 
- The aim of the study is to compare two methods of treating malnutrition in children between the ages of 12 
and 60 months, treated with either F100 or Ready-to-use Therapeutic Food.  
- The child will be treated with either F100 or Ready-to-use Therapeutic Food in accordance with the child’s 
nutritional requirements. 
- Weekly weight, height and mid-upper arm circumference measurements will be taken by a trained nurse 
and trained dietician 
- Confidentiality will be maintained throughout the duration of the study. 
- A report on the findings will be submitted to the hospital and the KwaZulu-Natal Department of Health.  
I have been fully informed by ________________________________________about the study. 
I hereby agree voluntarily that my child can partake in the study and realize that my permission can be 
withdrawn at any time without affecting treatment. 
 
 
Signed at ___________________________ on ________________________________2012/13 
 
 
Guardian: ___________________________Witness: _______________________________. 
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ADDENDUM C 
 
Enquiries: Anele Nomvete 
Tel.: 031 451 5129 
           Date: 07 June 2012 
 
 
To: Mr. B. Gwala 
      CEO 
      Clairwood Hospital 
 
Dear Mr Gwala 
 
RE: PERMISSION TO CONDUCT  A RESEARCH STUDY FOR DEGREE PURPOSES AT 
CLAIRWOOD HOSPITAL. 
 
I Anele Nomvete, a student at the Nelson Mandela Metropolitan University, currently registered for a 
Masters in Health and Welfare Management, hereby request permission to conduct a pilot study at 
Clairwood Hospital for degree purposes. 
 
The aim of the study is to evaluate the recovery of clinically stable severe acute malnourished children, 
between 12 and 60 months, treated with either F100 or Ready-to-use Therapeutic Food (RUTF). F100 
formula is part of the ten steps in recommended by the WHO in the treatment of severe acute malnutrition 
and is currently used in treatment of severe malnutrition children in Clairwood hospital. The RUTF is a 
nutrient dense supplement also used at Clairwood hospital and is available on the government RT9 contract. 
 
The ready-to-use therapeutic supplement will be provided by Diva Nutritional Products and therefore will 
not have cost implications for government. 
Informed consent will be obtained from legal guardians of the children that will be participating in the 
study. 
 
A report will be written on completion of the study and presented to the management of the hospital. 
 
Ethical approval will be obtained from the Research Ethics Committee (REC) – Human, (NMMU), and the 
study will not be conducted without the ethical approval certificate. 
 
Your approval for conducting the study in Clairwood Hospital will be appreciated. 
 
Yours sincerely 
 
 
 
Anele Nomvete 
Chief  Dietician 
Clairwood Hospital 
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ADDENDUM D 
QUESTIONNAIRE ON NUTRITIONAL ASSESSMENT 
 
Reference Number: _______________ 
 
Date: __________________________ 
 
D.O.B:___________________     Age: _______  Sex: M/F  Language:______________ 
 
 
ANTHROPOMETRY 
 
 
Name of child Date Week Weight (kg) Height (cm) MUAC Growth 
velocity 
 
 
 
 
 
 
Baseline 
    
 
 
 
 
 
 
 
 
 
Week 1 
    
 
 
 
 
Week 2 
    
 
 
 
 
Week 3 
    
 
 
 
 
Week 4 
    
 
 
 
 
 
 
 
Week 6 
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DIETARY INFORMATION 
 
        Food intake 
 Date Ward diet F100 
(ml) 
Ready-to-use Therapeutic 
food 
(amount/no. of sachets) 
Week 1  
   
Week 2  
   
Week 3  
   
Week 4  
   
Week 6  
   
 
CLINICAL SIGNS 
 
Give a brief description of clinical signs: 
 
 
 
 
 
 
POSSIBLE CAUSES OF POOR FOOD INTAKE THAT INFLUENCE WEIGHT GAIN 
 
 
       (Please tick if any of the above symptoms present) 
 
 
 
 Diarrhoea  Vomiting Nausea  Increased 
temperature 
Oral thrush Cough 
Week 1   
    
Week 2   
    
Week 3   
    
Week 4   
    
Week 6    
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DISEASES 
 
   
 
 
 
 
TB 
RVD+ Cancer  Diabetes 
Other (Specify): 
 
(Please t(Please tick if child is known to have any of the above diseases) 
 
RETENTION 
 
 
 Total number of children 
in the study  
Number of children 
exiting the programme 
before completion 
 
Total number of children 
that completed the 
programme 
 
 
Week 1 
  
 
 
 
 
Week 2 
  
 
 
 
 
Week 3 
  
 
 
 
 
Week 4 
  
 
 
 
 
Week 6 
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ADDENDUM E 
 
 
EXPLANATION OF THE PURPOSE FOR THIS RESEARCH TO THE PARENTS AND LEGAL 
GUARDIANS 
 
 
To: Parents and legal guardians of children with severe acute malnutrition at Clairwood hospital. 
 
Re: Purpose of the research 
 
I am Anele Nomvete, I am currently studying Masters in Health and Welfare Management at Nelson 
Mandela Metropolitan University in Port Elizabeth. 
Research forms part of my degree, and the area of interest for my research is the treatment of children 
between 12 and 60 months that are severely malnourished referred to Clairwood hospital for nutritional 
rehabilitation. Treatment will not have negative consequences.  
The results and recommendations will be presented to the management at Clairwood hospital and to the 
KwaZulu-Natal department of Health. This will benefit the children as the outcomes will help to improve 
treatment of severe acute malnutrition. 
 
I hereby request your co-operation. 
 
Thank you 
 
 
 
________________ 
Anele Nomvete (researcher) 
11 June 2012 
 
Contact details if more information is required: Dietetics Department 
          Clairwood Hospital 
          Mobeni 
          4060 
          Tel: 031 451 5000 ext 5129 
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ADDENDUM F 
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ADDENDUM G 
 
 
